Epitope-specific antibody response to Mel-CAM induced by mimotope immunization

Journal of Investigative Dermatology

Volumn 124, Issue 1, 2005, Pages 125-131

  Hafner, Christine ^a   Wagner, Stefan ^a   Jasinska, Joanna ^a   Allwardt, Dorotnee ^a   Scheiner, Otto ^a   Wolff, Klaus ^a   Pehamberger, Hubert ^a   Wiedermann, Ursula ^a   Breiteneder, Heimo ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibody response; Mel CAM; Melanoma; Mimotope

Indexed keywords

CD146 ANTIGEN; CELL ADHESION MOLECULE; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TETANUS TOXOID; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 11944272311     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23515.x     Document Type: Article

References (27)

1. Apostolopoulos V, Matsoukas J, Plebanski M, Mavromoustakos T: Applications of peptide mimetics in cancer. Curr Med Chem 9:411-420, 2002
2. Apostolopoulos V, Sandrin MS, McKenzie IF: Mimics and cross reactions of relevance to tumour immunotherapy. Vaccine 18:268-275, 1999
3. Cunto-Amesty G, Monzavi-Karbassi B, Luo P, Jousheghany F, Kieber-Emmons T: Strategies in cancer vaccines development. Int J Parasitol 33:597-613, 2003
4. Felici F, Luzzago A, Monaci P, Nicosia A, Sollazzo M, Traboni C: Peptide and protein display on the surface of filamentous bacteriophage. Biotechnol Annu Rev 1:149-183, 1995
5. Hafner C, Samwald U, Wagner S, et al: Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide library. J Invest Dermatol 119:865-869, 2002
6. Hart SP, Smith JR, Dransfield I: Phagocytosis of opsonized apoptotic cells: Roles for 'old-fashioned' receptors for antibody and complement. Clin Exp Immunol 135:181-185, 2004
7. Johnson JP, Bar-Eli M, Jansen B, Markhof E: Melanoma progression- associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand. Int J Cancer 73:769-774, 1997
8. Kraus A, Masat L, Johnson JP: Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Melanoma Res 7 (Suppl. 2):S75-S81, 1997
9. Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G, Johnson JP: Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:641-645, 1967
10. Mahler M, Bluthner M, Pollard KM: Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin Immunol 107:65-79, 2003
11. McGary EC, Heimberger A, Mills L, et al: A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 9:6560-6566, 2003
12. Mills L, Tellez C, Huang S, et al: Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res 62: 5106-5114, 2002
13. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T: Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol 20:207-214, 2002
14. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Lees A, Kieber-Emmons T: Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals 29:249-257, 2001
15. Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-Quinones M, Cunto-Amesty G, Artaud C, Kieber-Emmons T: A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res 64:2162-2166, 2004
16. Olszewska W, Obeid OE, Steward MW: Protection against measles virus-induced encephalitis by anti-mimotope antibodies: The role of antibody affinity. Virology 272:98-105, 2000
17. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A: Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19:2237-2242, 1989
18. Portielje JE, Gratama JW, van Ojik HH, Stoter G, Kruit WH: IL-12: A promising adjuvant for cancer vaccination. Cancer Immunol Immunother 52:133-144, 2003
19. Satyamoorthy K, Muyrers J, Meier F, Patel D, Herlyn M: Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 20:4676-4684, 2001
20. Shin IM: The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189: 4-11, 1999
21. Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M: Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 57:3835-3840, 1997
22. Smith GP: Surface presentation of protein epitopes using bacteriophage expression systems. Curr Opin Biotechnol 2:668-673, 1991
23. Van Regenmortel MH: Pitfalls of reductionism in the design of peptide-based vaccines. Vaccine 19:2369-2374, 2001
24. Versteeg R, Peltenburg LT, Plomp AC, Schrier PI: High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J Immunol 143:4331-4337, 1989
25. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M: Expression ! of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 57:2295-2303, 1997
26. Yip YL, Ward RL: Application of phage display technology to cancer research. Curr Pharm Biotechnol 3:29-43, 2002
27. Zwick MB, Shen J, Scott JK: Phage-displayed peptide libraries. Curr Opin Biotechnol 9:427-436, 1998